Page last updated: 2024-08-21

methoxyhydroxyphenylglycol and triazoles

methoxyhydroxyphenylglycol has been researched along with triazoles in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (66.67)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Fuller, RW; Hemrick-Luecke, SK; Snoddy, HD	1
Birk, KL; Cohen, AF; De Puy, ME; De Smet, M; Fisher, AL; Goldberg, MR; Musson, DG; Sterrett, A; Van Gerven, JM; Van Haarst, AD	1
Fukaya, M; Hara, Y; Ito, A; Okamoto, H; Sakagami, H; Sugawara, T; Yamauchi, J	1

Trials

1 trial(s) available for methoxyhydroxyphenylglycol and triazoles

Article	Year
The effects of moclobemide on the pharmacokinetics of the 5-HT1B/1D agonist rizatriptan in healthy volunteers. British journal of clinical pharmacology, 1999, Volume: 48, Issue:2 Topics: Adult; Area Under Curve; Benzamides; Biotransformation; Blood Pressure; Cross-Over Studies; Double-Blind Method; Female; Half-Life; Humans; Male; Methoxyhydroxyphenylglycol; Moclobemide; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines	1999

Article

Year

The effects of moclobemide on the pharmacokinetics of the 5-HT1B/1D agonist rizatriptan in healthy volunteers.

British journal of clinical pharmacology, 1999, Volume: 48, Issue:2

Topics: Adult; Area Under Curve; Benzamides; Biotransformation; Blood Pressure; Cross-Over Studies; Double-Blind Method; Female; Half-Life; Humans; Male; Methoxyhydroxyphenylglycol; Moclobemide; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines

1999

Other Studies

2 other study(ies) available for methoxyhydroxyphenylglycol and triazoles

Article	Year
Evaluation of nefazodone as a serotonin uptake inhibitor and a serotonin antagonist in vivo. Life sciences, 1994, Volume: 55, Issue:7 Topics: Animals; Hypothalamus; Male; Methoxyhydroxyphenylglycol; Mice; Mice, Inbred ICR; Piperazines; Quipazine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Trazodone; Triazoles	1994
Cytohesin-2 mediates group I metabotropic glutamate receptor-dependent mechanical allodynia through the activation of ADP ribosylation factor 6 in the spinal cord. Neurobiology of disease, 2021, Volume: 159 Topics: ADP-Ribosylation Factor 1; ADP-Ribosylation Factor 6; Animals; GTPase-Activating Proteins; Hyperalgesia; Inflammation; MAP Kinase Signaling System; Methoxyhydroxyphenylglycol; Mice; Mice, Knockout; Neuralgia; Post-Synaptic Density; Posterior Horn Cells; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Spinal Cord; Spinal Cord Dorsal Horn; Triazoles	2021

Article

Year

Evaluation of nefazodone as a serotonin uptake inhibitor and a serotonin antagonist in vivo.

Life sciences, 1994, Volume: 55, Issue:7

Topics: Animals; Hypothalamus; Male; Methoxyhydroxyphenylglycol; Mice; Mice, Inbred ICR; Piperazines; Quipazine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Trazodone; Triazoles

1994

Cytohesin-2 mediates group I metabotropic glutamate receptor-dependent mechanical allodynia through the activation of ADP ribosylation factor 6 in the spinal cord.

Neurobiology of disease, 2021, Volume: 159

Topics: ADP-Ribosylation Factor 1; ADP-Ribosylation Factor 6; Animals; GTPase-Activating Proteins; Hyperalgesia; Inflammation; MAP Kinase Signaling System; Methoxyhydroxyphenylglycol; Mice; Mice, Knockout; Neuralgia; Post-Synaptic Density; Posterior Horn Cells; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Spinal Cord; Spinal Cord Dorsal Horn; Triazoles

2021